Sildenafil Tablet, Film Coated
Product Images NDC 33342-121

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 33342-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of a medication known as Sildenafil Tablets that come in 20 mg. The tablets are packaged in 10-unit doses in a box of 100 tablets. The manufacturer is Macleods Pharma USA, Inc. and the product is manufactured by Macleods Phamiaceuticals Ltd in Baddi, Himachal Pradesh, India. The code for the product is HPI15207. The tablets are film-coated and each tablet contains 1020 mg of sidenafi (which is presumably a typo for sildenafil citrate). The medication should be stored at temperatures between 15° to 30° Celsius. The instructions for dosage and administration can be found on the prescribing information.*

FDA Label Image

Foil (Foil)

FDA Label Image

Sildenafil 20mg 90s

RadEoDs is a medication containing sildenafil citrate in a dosage of 20 mg per film-coated tablet. It is stored at room temperature and excursions to higher or lower temperatures are permitted within specified limits. Dispensing should be done in tight containers according to USP regulations, and patients receive a leaflet with information. It is manufactured by Macleods Pharmaceuticals in India for Macleods Pharma USA. Dosage and administration information can be found in the prescribing information.*

FDA Label Image

Figure-10 (Sildenafil Fig 10)

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Fig-12 (Sildenafil Fig 12)

FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

This is a table of medications and their recommended dose adjustments or lack thereof when used with another specific drug. The table also includes information on the fold change and 90% CI recommendation for interacting drugs, with a particular drug being the focus of each row. There is also a note about the lack of exercise capacity benefit when sildenafil is added to bosentan therapy.*

FDA Label Image

Figure-9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

The text provides a table of drug interactions, including Atorvastatin, Astromycin, Bosentan, Cimetidine, Everolimus, and more. The table lists the fold change and %0% CI recommendation for each drug, as well as any necessary dose adjustments. There is also a graph showing the change relative to Sildenafil alone with a vertical line at x=1 and a note that there is no benefit on exercise capacity when sildenafil is added to bosentan therapy according to clinical studies.*

FDA Label Image

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.